Tecan and GE Healthcare Collaborate for High Throughput Process Development
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Tecan and GE Healthcare are working together to bring increased quality and efficiency to process development by combining expertise in their respective fields of laboratory automation and protein purification.
The collaboration between the two suppliers focuses on high throughput screening of protein purification conditions, using the combination of Tecan’s Freedom EVO® automated workstation with GE Healthcare’s PreDictor™ 96-well plates pre-filled with BioProcess™ chromatography media.
According to Tecan, the throughput of its automation platform ensures reproducible results from GE Healthcare’s 96-well process development technology, providing efficient miniaturized, parallel screening performed in a multivariate fashion with minimal cross-contamination.
The combination of the technologies substantially shortens time spent on process development while allowing the investigation of a much larger experimental space, resulting in greater understanding of the process.
“With this collaboration, we have created a powerful solution for process development,” said Eric Willimann, Market Manager Protein Science, Tecan. “The combination of GE’s chemistry and Tecan’s hardware will provide our customers with a rapid and efficient method of screening process parameters, with minimal hands-on time.”
“Automated, parallel screening allows the process developer to quickly gain a greater overall understanding of the process,” said Catharina Hemstrom Nilsson, Market Program Manager, GE Healthcare. “Much more informed decisions can be made for process optimization, substantially shortening time-to-clinic. The data recorded are valuable from a regulatory perspective and help to define a robust manufacturing process.”
The collaboration between the two suppliers focuses on high throughput screening of protein purification conditions, using the combination of Tecan’s Freedom EVO® automated workstation with GE Healthcare’s PreDictor™ 96-well plates pre-filled with BioProcess™ chromatography media.
According to Tecan, the throughput of its automation platform ensures reproducible results from GE Healthcare’s 96-well process development technology, providing efficient miniaturized, parallel screening performed in a multivariate fashion with minimal cross-contamination.
The combination of the technologies substantially shortens time spent on process development while allowing the investigation of a much larger experimental space, resulting in greater understanding of the process.
“With this collaboration, we have created a powerful solution for process development,” said Eric Willimann, Market Manager Protein Science, Tecan. “The combination of GE’s chemistry and Tecan’s hardware will provide our customers with a rapid and efficient method of screening process parameters, with minimal hands-on time.”
“Automated, parallel screening allows the process developer to quickly gain a greater overall understanding of the process,” said Catharina Hemstrom Nilsson, Market Program Manager, GE Healthcare. “Much more informed decisions can be made for process optimization, substantially shortening time-to-clinic. The data recorded are valuable from a regulatory perspective and help to define a robust manufacturing process.”
